Huawei WATCH D3 goes on sale from RMB 2,988 with first low-interference ambulatory blood-pressure study
华为WATCH D3开售：首创轻扰动态血压研究，打造“腕上智能血压专家”
- Who
- 华为
- When
What happened
Huawei WATCH D3 went on sale on September 29 starting at RMB 2,988, or RMB 2,540 after government subsidies. It introduces what Huawei calls the industry's first 'low-interference ambulatory blood-pressure study', combining oscillometry and PPG with four micropump measurements during the day and three at night. It is registered as a Class II medical device with China's NMPA and has European CE-MDR certification. The device is 11.3 mm thick, with a 1.92-inch AMOLED display and 17 health indicators in its upgraded quick health check.
Keep reading
Latest daily · Issue 24NVIDIA and AI4Bharat Introduce Nemotron-pretraining-Indic-v1 and an Open Data Generation PipelineTrending now
- 1Meta Releases Muse Spark Open With Mac and Cloud Support, Topping US Open-Weight Index
- 2Google Launches Gemini 4 Argon Globally, Expands Paid Access as Benchmark Results Vary
- 3OpenAI Updates GPT-6 Astra Pro in ChatGPT With Parallel Agents and Faster Responses
- 4Meta’s New Business Terms Raise Dispute Over Website Crawling and AI Training Rights
Tomorrow at 08:00, a briefing like this arrives in your inbox.
The same kind of briefing as the one above: a few stories worth reading. Free. Mail starts after you confirm, and every letter has a one-click unsubscribe. Read a past issue · 2026-10-17